On January 20, 2026, Corvus Pharmaceuticals saw its stock price nearly triple following the release of Phase 1 clinical trial... Read more
Category: Uncategorized
Johnson & Johnson Eyes $100B Sales Milestone Amid Patent Pressures
In its financial report released January 21, 2026, Johnson & Johnson (J&J) set an ambitious target for the upcoming year,... Read more
Novavax Enters $530 Million Licensing Agreement with Pfizer
Novavax and Pfizer have announced a non-exclusive licensing agreement, marking a pivotal strategic shift for Novavax in 2026. Under the... Read more
Pfizer CEO evaluates the current state of U.S. vaccine policy
During a World Economic Forum event in Davos, Switzerland, Pfizer CEO Albert Bourla offered candid insights into the current healthcare... Read more
President Trump reverses tariff threats against European allies
Just days after issuing a stern warning to impose new tariffs on eight European nations, President Donald Trump has officially... Read more
Legal turning point in Johnson & Johnson talc litigation in the U.S.
A court-appointed special master in New Jersey has recommended that plaintiffs be allowed to present expert witness testimony in the... Read more
Artificial Intelligence: A new assistant for hospital pharmacists in clinical practice
In an effort to modernize the healthcare sector and accelerate digital transformation, a specialized training program on Artificial Intelligence (AI)... Read more
Strategic Vision for Vietnam’s Healthcare: Towards a Fee-Free Medical Era
Resolution No. 72-NQ/TW of the Politburo is ushering in a new era for Vietnam's healthcare sector with a breakthrough management... Read more
Leadership appointment at the National Institute of Forensic Psychiatry
On the morning of January 22, 2026, a significant administrative ceremony was held in Nghe An province to announce new... Read more









